Publications by authors named "Kamil Wezyk"
Introduction: Direct oral anticoagulants (DOAC) are the first-line treatment for primary and secondary acute ischaemic stroke (AIS) prevention in patients with nonvalvular atrial fibrillation (NVAF), but a significant percentage of patients develop AIS despite being treated with DOAC. As the number of DOAC-treated patients is growing, so is the number of patients with AIS on DOAC. The aim of the study was to assess the incidence of AIS with prestroke DOAC treatment among patients hospitalised in the University Hospital in Kraków, to analyse the clinical characteristics of AIS occurring in patients on DOAC, and to identify potential causes of treatment ineffectiveness in this group.
View Article and Find Full Text PDFBackground: Paraneoplastic neurological syndromes (PNS) affecting the CNS (central nervous system) are rare, presenting in less than 1% of all those with cancer. The pathogenesis of paraneoplastic neurological syndromes is not fully understood, but it is presumed to result from an immune attack on the underlying malignancy. The presence of different types of onconeural antibodies may occur in different tumors and can lead to different clinical manifestations, making the early detection of cancers challenging.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to identify neurological symptoms in COVID-19 patients during their first 14 days of hospitalization and how these symptoms relate to mortality rates.
- Out of 200 patients, 84.5% experienced neurological symptoms like fatigue, decreased mood, and muscle weakness, with notable differences between those who survived and those who died.
- Key findings revealed that older patients with severe symptoms like decreased consciousness and strokes had a higher mortality risk, suggesting the importance of monitoring neurological signs in COVID-19 patients.
Introduction: The study assessed the prevalence and risk factors for SARS-CoV-2 infection in patients with epilepsy (PWE). Additionally, the course of COVID-19 and its impact on seizure control was investigated.
Material And Methods: Subjects with definite (confirmed by positive RT-PCR nasopharyngeal swab or serum anti-SARS-CoV-2 antibodies) and probable COVID-19 were identified via telephone survey among PWE treated at the university epilepsy clinic.
Aim Of Study: To evaluate the rate and factors predicting seizure remission in a large cohort of patients with epilepsy.
Materials And Methods: Patients with epilepsy treated at a university epilepsy clinic were included in this study. The following information was collected by means of a structured questionnaire: age, sex, age at onset of epilepsy, aetiology of epilepsy, the presence of intellectual disability, duration and type of epilepsy, frequency of seizures, treatment of epilepsy, and mechanism of action of antiepileptic drugs (AEDs).